Exophytic Shoulder Mass as Initial Presentation of a Neglected Melanoma
P.B.-S. and C.G.-C. have nothing to declare. S.P. declares research grants/trials from Almirall, Pfizer, Regeneron, Sanofi, La Roche Posay, Philogen, ISDIN, International School of Derma, and consulting fees from Sanofi, Regeneron, ISDIN, L'Oreal, La Roche Posay, International School of Derma, and speaker fees from Sanofi, Sun pharma, Cantabria, Eucerin, ISDIN, L'Oreal, La Roche Posay, Almirall, Avene, Pierre Fabre, and support for attending meetings and/or travel from Almirall, Cantabria, ISDIN, L'Oreal. The data that support the findings of this study are available from the corresponding author upon reasonable request.
Authors
- Claudia Guilarte-Cadavide
- Pablo Balado-Simó (ORCID: https://orcid.org/0009-0006-1751-8959)
- Susana Puig
- Natalia Castrejón-de-Anta
Institutions
- Instituto de Salud Carlos III (ES)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- Hospital Clínic de Barcelona (ES)
- Universitat de Barcelona (ES)
Publication Details
- Journal
- International Journal of Dermatology
- Published
- 2026-02-26
- DOI
- https://doi.org/10.1111/ijd.70369
- Primary Topic
- Cutaneous Melanoma Detection and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00